Company fact sheet
05.05.2008
Nanobiotix is an emerging nanomedicine company combining dramatic advances in nanotechnology and molecular biology to develop nanoXray™— a technology platform that is expected to be turned ‘on’ and ‘off ’ outside the body to selectively treat a variety of cancers safely and noninvasively. NanoXray consists of non-drug nanoparticles, designed to be introduced by injection, which then attach themselves only to specifically targeted cancer cells.
Corporate profile
04.23.2008
Groundbreaking nanoXrayTM cancer therapy may enable the precise ‘on/off’ and selective extermination of cancer cells practically anywhere in the body: Treating cancer width one injection and an X-ray ?
CEO Profile
04.22.2008
30-Something’ Nanotech Mastermind Laurent Levy Wants To Play the Seminal Role In Making Cancer Treatments More Effective, Less Deadly To Healthy Tissues.
Technology profile
04.21.2008
Small wonders The nanoXray™ technology developed by Nanobiotix uses miniscule particles to dramatically improve the efficiency of radiation therapy in the treatment of cancer.